This antiviral drug will prevent HIV-1 infection of DCs (i.e. cis-infection) without altering their ability to transmit virions located on their surface and/or within their endosomal apparatus (i.e. trans-infection) to CD4+ T cells. The gene discussed is CD4; the disease is HIV-1 infection.